From 'points' to 'profiles' in intracavitary brachytherapy of cervical cancer

Current Opinion in Obstetrics and Gynecology

Volumn 17, Issue 1, 2005, Pages 35-41

  Datta, Niloy Ranjan ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cervical cancer; Computerized tomography; Intracavitary brachytherapy; Magnetic resonance imaging; Positron emission tomography

Indexed keywords

BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INTRACAVITARY BRACHYTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; REVIEW; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME; TREATMENT PLANNING; UTERINE CERVIX CANCER;

EID: 14644414187     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-200502000-00007     Document Type: Review

References (53)

1. Nori D, Dasari N, Allbright RM. Gynecologic brachytherapy I: proper incorporation of brachytherapy into the current multimodality management of carcinoma of the cervix. Semin Radiat Oncol 2002; 12:40-52.
2. Nag S, Erickson B, Thomadsen B, et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000; 48:201-211.
3. Loizzi V, Cormio G, Loverro G, et al. Chemoradiation: a new approach for the treatment of cervical cancer. Int J Gynecol Cancer 2003; 13:580-586. This paper reviews and analyses the implications of the six major randomized trials conducted using chemoradiation in cervical cancer.
4. Long HJ III. Current research directions for locally advanced cervix cancer. Curr Oncol Rep 2003; 5:468-472. A review on the present state of approaches for the management of locally advanced cervical cancer. It highlights the fact that chemoradiation approaches should be supplemented with adequate care during radiation therapy planning. Diagnostic modalities such as PET could be considered to be an effective non-surgical staging procedure for radiotherapy treatment planning.
5. Hanks GE, Herring DF, Kramer S. Patterns of care outcome studies: results of the National Practice in Cancer of the Cervix. Cancer 1983; 51:959-967.
6. Coia L, Won M, Lanciano R, et al. The Patterns of Care Outcome Study for cancer of the uterine cervix: results of the Second National Practice Survey. Cancer 1990; 66:2451-2456.
7. Logsdon MD, Eifel PJ. FIGO IIIB Squamous cell carcinoma of the cervix; an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 1999; 43:763-775.
8. Lee K, Park K, Kim C, et al. High-dose-rate versus low-dose-rate intracavitary radiotherapy in the treatment of cervical carcinoma: a meta-analysis [Abstract]. Int J Radiat Oncol Biol Phys 2003; 57:339.
9. Nag S, Dally M, de la Torre M, et al. Recommendations for implementation of high dose rate 192Ir brachytherapy in developing countries by the Advisory Group of International Atomic Energy Agency. Radiother Oncol 2002; 64:297-308.
10. Tod MC, Meredith WJ. A dosage system for use in the treatment of cancer of the uterine cervix. Br J Radiol 1938; 11:809-823.
11. Tod MC, Meredith WJ. Treatment of cancer of the cervix uteri: a revised "Manchester method". Br J Radiol 1953; 26:252-257.
12. Eifel PJ, Moughan J, Erickson B, et al. Patterns of radiotherapy practice for patients with carcinoma of the cervix (1996-1999): a Patterns-of-Care Study [Abstract]. Int J Radiat Oncol Biol Phys 2003; 57:S190.
13. Datta NR, Kumar S, Maria Das KJ, et al. Variations of intracavitary applicator geometry during multiple HDR brachytherapy insertions in carcinoma cervix and its influence on reporting as per ICRU report 38. Radiother Oncol 2001; 60:15-24.
14. Elhanafy OA, Das RK, Paliwal BR, et al. Anatomic variation of prescription points and treatment volume with fractionated high-dose-rate gynecological brachytherapy. J Appl Clin Med Phys 2002; 2:114-120.
15. Hoskin PJ, Cook M, Bouscale D, Cansdale J. Changes in applicator position with fractionated high dose rate gynaecological brachytherapy. Radiother Oncol 1996; 40:59-62.
16. King GC, Bloomer WD, Kalnicki S, et al. Point dose variations with time during traditional brachytherapy for cervical carcinoma. Med Dosim 2000; 25: 77-80.
17. Wulf J, Popp K, Oppitz U, et al. Positional variability of a tandem applicator system in HDR brachytherapy for primary treatment of cervix cancer. Analysis of the anatomic pelvic position and comparison of the applicator positions during five insertions. Strahlenther Onkol 2004; 180:216-224. A retrospective analysis for evaluating the intra-individual and inter-individual HDR ICRT applicator variability observed in 92 patients undergoing multiple HDR applications.
18. Datta NR, Basu R, Das KJM, et al. Problems and uncertainties with multiple point A's during multiple high-dose-rate intracavitary brachytherapy in carcinoma of the cervix. Clin Oncol 2004; 16:129-137. A systematic analysis to show the uncertainties that are evident when dose prescriptions are based on point A during multiple HDR ICBT applications.
19. Lee CM, Shrieve DC, Gaffney DK. Rapid involution and mobility of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2004; 58:625-630. The paper describes the quantum of involution and mobility in cases of carcinoma of the cervix undergoing chemoradiotherapy and highlights its implications during radiotherapy planning.
20. ICRU Report 38. Dose and volume specification for reporting intracavitary therapy in gynaecology. Bethesda, Maryland: International Commission on Radiation Units and Measurements; 1985.
21. Datta NR, Basu R, Das KJM, et al. Problems in reporting doses and volumes during multiple high-dose-rate intracavitary brachytherapy for carcinoma cervix as per ICRU Report 38: a comparative study using flexible and rigid applicators. Gynecol Oncol 2003; 91:285-292. The paper highlights the problems that are associated with the reporting of doses and the dimensions of the various ICRU volumes as per the recommendations of ICRU, irrespective of the type of applicators used that are recommended in the ICRU report 38 for ICBT in carcinoma of the cervix.
22. Potter R, Limbergen EV, Gerstner N, Wambersie A. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy. Radiother Oncol 2001; 58:11-18.
23. Lewis GC, Raventos A, Hale J. Space dose relationships for points A and B in radium therapy of cancer of the uterine cervix. Am J Roentgenol 1960; 83:432-446.
24. Katz A, Eifel PJ. Quantification of intracavitary brachytherapy parameters and correlation with outcome in patients with carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000; 48:1417-1425.
25. Petereit DG, Pearcey R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule? Int J Radiat Oncol Biol Phys 1999; 43:359-366.
26. Hricak H, Yu KK. Radiology in invasive cervical cancer. Am J Roentgenol 1996; 167:1101-1108.
27. Kim SH, Choi BI, Lee HP, et al. Uterine cervical carcinoma: comparison of CT and MR findings. Radiology 1990; 175:45-51.
28. Schneider A, Hertel H. Surgical and radiographic staging in patients with cervical cancer. Curr Opin Obstet Gynecol 2004; 16:11-18. A comprehensive review on the present state of staging for cervical cancer by surgical and imaging modalities namely CT, MRI and PET.
29. Eifel PJ. Accurate diagnosis of regional metastasis from cervical cancer: is PET the answer? Int J Radiat Oncol Biol Phys 2004; 59:637-633. An editorial highlighting the advantages of using functional images through PET for better regional nodal metastasis detection in cervical cancer.
30. Grigsby PW, Singh AK, Siegel BA, et al. Lymph node control in cervical cancer. Int J Radiat Oncol Biol Phys 2004; 59:709-712. An elegant study in 209 patients to evaluate the pretreatment lymph node size as assessed by CT and PET, the dose of radiation with the long-term pelvic and para-aortic nodal control rates and overall survival.
31. Perez CA, Grigsby PW, Zoberi I. Uncertainties in radiation therapy: target definition in carcinoma of the uterine cervix. Rays 2003; 28:247-265. An excellent review of the various imaging modalities in cervical cancer, which would help in accurate target definition and precision of radiation therapy planning.
32. Perez CA, Bradley J, Chao CK, et al. Functional imaging in treatment planning in radiation therapy: a review. Rays 2002; 27:157-173.
33. DeWitt KD, Hsu IJ, Weinberg VK, et al. 3-D Inverse treatment planning and optimization for the tandem and ovoid applicator in cervical cancer [abstract]. Int J Radiat Oncol Biol Phys 2003; 57:S340.
34. Pouliot J, Charra-Brunaud C, Kim Y, et al. Inverse planning for HDR brachytherapy: clinical implementation [abstract]. Int J Radiat Oncol Biol Phys 2002; 54:333.
35. Petereit DG, Fowler JF. High-dose-rate brachytherapy - high dose, high-tech, and high results. Int J Radiat Oncol Biol Phys 2003; 55: 159-1161. An editorial highlighting the present state of practice of HDR intracavitary treatments and providing the future directions in HDR ICRT.
36. Fellner C, Potter R, Knocke TH, Wambersie A. Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects. Radiother Oncol 2001; 58:53-62.
37. Hellebust TP, Dale E, Skjonsberg A, Olsen DR. Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations. Radiother Oncol 2001; 60:273-280.
38. Kim RY, Pareek P. Radiography-based treatment planning compared with computed tomography (CT)-based treatment planning for intracavitary brachytherapy in cancer of the cervix: analysis of dose-volume histograms. Brachytherapy 2003; 2:200-206. An excellent study that carries out a comparative analysis of the radiography-based and CT-based treatment planning as for HDR ICBT planning and highlights the need for image-based brachytherapy treatment planning.
39. Low DA, Grigsby PW, Dempsey JF, et al. Applicator-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2002; 52:1400-1406.
40. Ohara K, Tanaka YO, Sugahara S, Itai Y. Preliminary estimation of minimum target dose in intracavitary radiotherapy for cervical cancer. Radiat Med 2001; 19:193-196.
41. Pelloski CE, Palmer MB, Chronowski GM, et al. CT-based volumetric dosimetry of intracavitary brachytherapy for cervical cancer [abstract]. Int J Radiat Oncol Biol Phys 2003; 57:S343.
42. Schoeppel SL, Ellis JH, LaVigne ML, et al. Magnetic resonance imaging during intracavitary gynecologic brachytherapy. Int J Radiat Oncol Biol Phys 1992; 23:169-174.
43. Cheng J, Peng L, Cheng Y, et al. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy [abstract]. Int J Radiat Oncol Biol Phys 2003; 57:S341.
44. Wachter-Gerstner N, Wachter S, Reinstadler E, et al. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point. Radiother Oncol 2003; 68:269-276. The study analyses the correlation between ICRU rectum and bladder point doses and those obtained through MRI-based dose-volume histograms.
45. Wachter-Gerstner N, Wachter S, Reinstadler E, et al. The impact of sectional imaging on dose escalation in endocavitary brachytherapy of cervical cancer: results of a prospective comparative trial. Radiother Oncol 2003; 68:51-59. This excellent paper reports on the comparative evaluation of dose distribution in HDR ICBT based on orthogonal radiographs and on sectional images obtained through CT or MRI.
46. Mai J, Rownd J, Erickson B. CT-guided high-dose-rate dose prescription for cervical carcinoma: the importance of uterine wall thickness. Brachytherapy 2002; 1:27-35.
47. Schoeppel SL, LaVigne ML, Martel MK, et al. Three dimensional treatment planning of intracavitary gynaecologic implants: analysis of ten cases and implications for dose specification. Int J Radiat Oncol Biol Phys 1994; 28:277-283.
48. Terahara A, Nakano T, Ishikawa A, et al. Dose-volume histogram analysis of high dose rate intracavitary brachytherapy for uterine cervix cancer. Int J Radiat Oncol Biol Phys 1996; 35:549-554.
49. Mutic S, Malyapa RS, Grigsby PW, et al. PET guided IMRT for cervical carcinoma with positive para-aortic lymph nodes - a dose escalation treatment planning study. Int J Radiat Oncol Biol Phys 2003; 55:201-211. The paper explores the feasibility of using CT and PET along with image co-registration procedures to carry out dose-escalation during radiation therapy of cervical cancer.
50. Malyapa RS, Mutic S, Low DA, et al. Physiologic FDG-PET three-dimensional brachytherapy treatment planning for cervical cancer. Int J Radiat Oncol Biol Phys 2002; 54:1140-1146.
51. Eisbruch A, Johnston CM, Martel MK, et al. Customized gynecologic interstitial implants: CT-based planning, dose evaluation, and optimization aided by laparotomy. Int J Radiat Oncol Biol Phys 1998; 40:1087-1093.
52. Mundt AJ, Roeske JC. Can intensity-modulated radiation therapy replace brachytherapy in the management of cervical cancer? Counterpoint. Brachytherapy 2002; 1:192-194.
53. Alektiar KM. Can intensity-modulated radiation therapy replace brachytherapy in the management of cervical cancer? Point. Brachytherapy 2002; 1: 191-192.